Affiliation:
1. 1Princess Margaret Cancer Centre
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Reference10 articles.
1. Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma;Santoro;Blood,2023
2. Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations;Eberle;Mod Pathol,2011
3. Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma;Green;Blood,2010
4. Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas;Svoboda;Haematologica,2021
5. PD-1 blockade in mediastinal gray-zone lymphoma;Melani;N Engl J Med,2017
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献